Kate Haining1, Claire Matrunola2, Lucy Mitchell1, Ruchika Gajwani2, Joachim Gross1,3, Andrew I Gumley3, Stephen M Lawrie4, Matthias Schwannauer5, Frauke Schultze-Lutter6, Peter J Uhlhaas1. 1. Institute for Neuroscience and Psychology, University of Glasgow, Glasgow, UK. 2. Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK. 3. Institute of Biomagnetism and Biosignalanalysis, Westphalian Wilhelms University Muenster, Muenster, Germany. 4. Department of Psychiatry, University of Edinburgh, Edinburgh, UK. 5. Department of Clinical Psychology, University of Edinburgh, Edinburgh, UK. 6. Department of Psychiatry and Psychotherapy, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Abstract
BACKGROUND: The current study examined the pattern of neurocognitive impairments in a community-recruited sample of clinical high-risk (CHR) participants and established relationships with psychosocial functioning. METHODS: CHR-participants (n = 108), participants who did not fulfil CHR-criteria (CHR-negatives) (n = 42) as well as a group of healthy controls (HCs) (n = 55) were recruited. CHR-status was assessed using the Comprehensive Assessment of At-Risk Mental States (CAARMS) and the Schizophrenia Proneness Instrument, Adult Version (SPI-A). The Brief Assessment of Cognition in Schizophrenia Battery (BACS) as well as tests for emotion recognition, working memory and attention were administered. In addition, role and social functioning as well as premorbid adjustment were assessed. RESULTS: CHR-participants were significantly impaired on the Symbol-Coding and Token-Motor task and showed a reduction in total BACS-scores. Moreover, CHR-participants were characterised by prolonged response times (RTs) in emotion recognition as well as by reductions in both social and role functioning, GAF and premorbid adjustments compared with HCs. Neurocognitive impairments in emotion recognition accuracy, emotion recognition RT, processing speed and motor speed were associated with several aspects of functioning explaining between 4% and 12% of the variance. CONCLUSION: The current data obtained from a community sample of CHR-participants highlight the importance of dysfunctions in motor and processing speed and emotion recognition RT. Moreover, these deficits were found to be related to global, social and role functioning, suggesting that neurocognitive impairments are an important aspect of sub-threshold psychotic experiences and a possible target for therapeutic interventions.
BACKGROUND: The current study examined the pattern of neurocognitive impairments in a community-recruited sample of clinical high-risk (CHR) participants and established relationships with psychosocial functioning. METHODS:CHR-participants (n = 108), participants who did not fulfil CHR-criteria (CHR-negatives) (n = 42) as well as a group of healthy controls (HCs) (n = 55) were recruited. CHR-status was assessed using the Comprehensive Assessment of At-Risk Mental States (CAARMS) and the Schizophrenia Proneness Instrument, Adult Version (SPI-A). The Brief Assessment of Cognition in Schizophrenia Battery (BACS) as well as tests for emotion recognition, working memory and attention were administered. In addition, role and social functioning as well as premorbid adjustment were assessed. RESULTS:CHR-participants were significantly impaired on the Symbol-Coding and Token-Motor task and showed a reduction in total BACS-scores. Moreover, CHR-participants were characterised by prolonged response times (RTs) in emotion recognition as well as by reductions in both social and role functioning, GAF and premorbid adjustments compared with HCs. Neurocognitive impairments in emotion recognition accuracy, emotion recognition RT, processing speed and motor speed were associated with several aspects of functioning explaining between 4% and 12% of the variance. CONCLUSION: The current data obtained from a community sample of CHR-participants highlight the importance of dysfunctions in motor and processing speed and emotion recognition RT. Moreover, these deficits were found to be related to global, social and role functioning, suggesting that neurocognitive impairments are an important aspect of sub-threshold psychotic experiences and a possible target for therapeutic interventions.
Authors: Larry J Seidman; Anthony J Giuliano; Eric C Meyer; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Thomas H McGlashan; Diana O Perkins; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Bruce K Christensen; Keith Hawkins; Robert Heaton; Richard S E Keefe; Robert Heinssen; Barbara A Cornblatt Journal: Arch Gen Psychiatry Date: 2010-06
Authors: S van Rijn; A Aleman; L de Sonneville; M Sprong; T Ziermans; P Schothorst; H van Engeland; H Swaab Journal: Psychol Med Date: 2010-05-27 Impact factor: 7.723
Authors: Todd Lencz; Christopher W Smith; Danielle McLaughlin; Andrea Auther; Emilie Nakayama; Lauren Hovey; Barbara A Cornblatt Journal: Biol Psychiatry Date: 2005-12-01 Impact factor: 13.382
Authors: L B Glenthøj; J R M Jepsen; C Hjorthøj; N Bak; T D Kristensen; C Wenneberg; K Krakauer; M Nordentoft; B Fagerlund Journal: Acta Psychiatr Scand Date: 2016-12-18 Impact factor: 6.392
Authors: Ricardo E Carrión; Terry E Goldberg; Danielle McLaughlin; Andrea M Auther; Christoph U Correll; Barbara A Cornblatt Journal: Am J Psychiatry Date: 2011-05-02 Impact factor: 18.112
Authors: Warrick J Brewer; Shona M Francey; Stephen J Wood; Henry J Jackson; Christos Pantelis; Lisa J Phillips; Alison R Yung; Vicki A Anderson; Patrick D McGorry Journal: Am J Psychiatry Date: 2005-01 Impact factor: 18.112
Authors: D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar Journal: J Clin Psychiatry Date: 1998 Impact factor: 4.384
Authors: Tara A Niendam; Carrie E Bearden; Jamie Zinberg; Jennifer K Johnson; Mary O'Brien; Tyrone D Cannon Journal: Schizophr Bull Date: 2007-04-09 Impact factor: 9.306
Authors: Paul Klauser; Vanessa L Cropley; Philipp S Baumann; Jinglei Lv; Pascal Steullet; Daniella Dwir; Yasser Alemán-Gómez; Meritxell Bach Cuadra; Michel Cuenod; Kim Q Do; Philippe Conus; Christos Pantelis; Alex Fornito; Tamsyn E Van Rheenen; Andrew Zalesky Journal: Schizophr Bull Open Date: 2021-07-17
Authors: Ingvild Aase; Johannes Hendrik Langeveld; Jan Olav Johannessen; Inge Joa; Ingvild Dalen; Wenche Ten Velden Hegelstad Journal: Schizophr Res Cogn Date: 2021-07-28
Authors: Kate Haining; Ruchika Gajwani; Joachim Gross; Andrew I Gumley; Robin A A Ince; Stephen M Lawrie; Frauke Schultze-Lutter; Matthias Schwannauer; Peter J Uhlhaas Journal: Eur Arch Psychiatry Clin Neurosci Date: 2021-08-16 Impact factor: 5.270
Authors: Lorna Staines; Ruchika Gajwani; Joachim Gross; Andrew I Gumley; Stephen M Lawrie; Matthias Schwannauer; Frauke Schultze-Lutter; Peter J Uhlhaas Journal: BMC Psychiatry Date: 2021-07-07 Impact factor: 3.630
Authors: Vijay A Mittal; Lauren M Ellman; Gregory P Strauss; Elaine F Walker; Philip R Corlett; Jason Schiffman; Scott W Woods; Albert R Powers; Steven M Silverstein; James A Waltz; Richard Zinbarg; Shuo Chen; Trevor Williams; Joshua Kenney; James M Gold Journal: J Psychiatr Brain Sci Date: 2021-06-29
Authors: Gabriel G De la Torre; Sandra Doval; David López-Sanz; Manuel García-Sedeño; Miguel A Ramallo; Macarena Bernal; Sara González-Torre Journal: Brain Sci Date: 2021-03-19